The influence of antidiabetic combined medicinal product glikverin based on voglibose and quercetin on lipid exchange indices under conditions of experimental metabolic syndrome

Abstract

At present, the prevalence of diabetes mel- litus (DM) has reached a pandemic scale and

is one of the most pressing public health is- sues worldwide. According to experts from the

International Diabetes Federation, 193 million people live with undiagnosed diabetes and are

also at risk of developing chronic complica- tions. It is projected that in 2045 the number

of patients with diabetes will reach 629 million people [1]. In Ukraine the number of registered patients with diabetes exceeds 1.8 million

people, among whom type 2 diabetes predomi- nates (90%)